SEC Filing Summary for Co-Diagnostics, Inc.

Richard Serbin, a director at Co-Diagnostics, Inc. (CODX), reported a transaction on May 23, 2026. He acquired 1695 shares of Common Stock and disposed of 1695 Restricted Stock Units. Following these transactions, Serbin holds 10751 shares of Common Stock and 4000 Restricted Stock Units. The Restricted Stock Units were awarded under the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan and vest in installments. Specifically, 2,334 units awarded on June 12, 2023, vest starting November 23, 2023. Another 3,667 units awarded on April 26, 2024, vest starting November 23, 2024. Lastly, 4,167 units awarded on August 13, 2025, vest starting November 23, 2025.